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Molecular studies of DO alleles 
reveal that JO is more prevalent 
than HY in Brazil, whereas HY  
is more prevalent in New York
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Because of the scarcity of anti-Hy and anti-Joa, hemagglutina-
tion typing for the Dombrock blood group system antigens, Hy 
and Joa, is not feasible.  The molecular bases associated with 
these antigens have been determined, making it possible to 
distinguish HY and JO from wild-type DO.  This provides a tool 
to predict the probable phenotype of patients and to screen 
for antigen-negative donors.  PCR-RFLP assays and a microchip 
assay were used to determine the frequency of HY and JO al-
leles in donors from Brazil and New York.  DNA from random 
Brazilian donors, 288 by PCR-RFLP and 599 by the bead array 
method (BeadChip, BioArray Solutions, Warren, NJ), was tested 
to determine 323G/T (HY+/HY–) and 350C>T ( JO+/JO–) single-
nucleotide polymorphisms.  In New York, 27,226 donors who 
self-identified as being African American were tested by hem-
agglutination with anti-Gya.  Nonreactive and weakly reactive 
samples were tested by PCR-RFLP for the same alleles as listed 
above.  In Brazil, 30 (3.4%) of the samples were JO/DO and 13 
(1.4%) were HY/DO.  In New York, of the samples that had HY or 
JO alleles, 14 were homozygous HY/HY, 132 were heterozygous 
HY/DO, 13 were heterozygous HY/JO, 14 were heterozygous 
JO/DO, and 3 were homozygous JO/JO.  These results show 
that in donors from Brazil, JO (30 alleles) is more than twice as 
prevalent as HY (13 alleles), whereas in donors from New York, 
HY (173 alleles) was more than five times more common than JO 
(33 alleles).  Immunohematology 2008;24:135–137.
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The Dombrock (Do) blood group system consists 
of five antigens: a pair of antithetical antigens (Doa 
and Dob) and three high-prevalence antigens (Gya, 
Hy, and Joa).1  The Gy(a–) phenotype is the null of 
the Dombrock system.2  The Hy-negative phenotype 
is associated with weak expression of Dob and Gya, 
and absent or very weak expression of Joa, and the 
Jo(a–) phenotype is associated with weak expression 
of Doa and Hy.1,3
In the transfusion setting, antibodies to antigens 
in the Dombrock blood group system have caused 
delayed, and rarely acute, transfusion reactions.  In 
the prenatal setting, they have caused a positive di-
rect antiglobulin test but not hemolytic disease of the 
newborn and fetus.4  Antigens in the Dombrock blood 
group system are carried on the Dombrock glycopro-
tein, which is encoded by the DO gene, also known 
as ART4.5  The molecular bases associated with the 
various Do phenotypes have been determined to be 
caused by single-nucleotide polymorphisms.5–7  Our 
ability to type RBCs for Hy and Joa by hemagglutina-
tion has been severely limited because of the scarcity 
of suitable antibodies.  As the molecular bases of 
these Dombrock blood group system antigens have 
been determined, the ability to distinguish HY and JO 
makes it feasible to predict the probable phenotype 
of patients and to screen for antigen-negative donors. 
Based on this knowledge, we used PCR-RFLP assays 
and a bead microchip assay to determine the relative 
frequency of HY and JO alleles in donors from Brazil 
and New York.
Materials and Methods
Genomic DNA was extracted from the buffy coat 
fraction from blood samples using a DNA extraction 
kit (QIAamp DNA Blood Mini Kit, QIAGEN, Inc., 
Valencia, CA).  PCR was performed using the follow-
ing conditions: 100 ng of each primer (synthesized 
by Life Technologies, Inc., Gaithersburg, MD), 200 
μM of each dNTP, 2.5 mM (for nt 323 and nt 350 
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of DO) or 3.0 mM MgCl2 (for nt 793 of DO), 1.0 U 
DNA polymerase (HotStar Taq, QIAGEN), and buffer 
in a total volume of 50 μL.  Amplification was per-
formed in a thermal cycler (GeneAmp PCR System 
2400, Perkin Elmer, Norwalk, CT) with the following 
profile: 95°C for 15 minutes; followed by 35 cycles 
of 94°C for 20 seconds; 58°C (for nt 323 and nt 350 
of DO) or 62°C (for nt 793 of DO) for 20 seconds 
and 72°C for 20 seconds; then 72°C for 7 minutes.7,8 
PCR products were analyzed by electrophoresis in 
1% agarose gel.  PCR-RFLP assays were performed 
as previously described.7,8  The sequence of primers, 
PCR product size, restriction enzyme used to digest 
each PCR-amplified product, and expected restric-
tion fragment sizes are given in Table 1.  Digested 
products were analyzed by electrophoresis in 8% 
polyacrylamide gel.
In Brazil, DNA samples from random Brazilian 
donors were tested by PCR-RFLP (n = 288) and by 
HEA bead microchip (n = 599; BeadChip, BioArray 
Solutions, Warren, NJ) to determine 793A>G 
(DO*A/DO*B), 323G>T (HY+/–), and 350C>T ( JO+/–) 
single-nucleotide polymorphisms.  The donors were 
predominantly of European and African descent, and 
a small number were of Asian descent.  In New York, 
27,226 (from September 1999 to April 2007) donors 
who self-identified as being African American were 
tested by hemagglutination with a polyclonal anti-
Gya by the IAT.  Nonreactive and weakly reactive 
samples were tested by PCR-RFLP for the same al-
leles as listed above.
Results
In Brazil, 21 (2.4%) typed as JO/DO*B, 9 (1.0%) 
as JO/DO*A, 5 (0.5%) as HY/DO*A, and 8 (0.9%) as 
HY/DO*B.  Thus, of donors who had HY or JO al-
leles, 30 were heterozygous JO in trans to a DO*B 
or DO*A, and 13 were heterozygous HY in trans to 
DO*A or DO*B (Table 2).  All donors with HY or JO 
alleles were Afro-Brazilians.
In New York, of the samples that had HY or JO 
alleles, 14 were homozygous HY/HY, 132 were het-
erozygous HY in trans to a DO*A or DO*B, 13 were 
heterozygous HY/JO, 3 were homozygous JO/JO, and 
14 were heterozygous JO in trans to a DO*A or DO*B 
(Table 2).
Discussion
In this study, in the Afro-Brazilians, JO (30 al-
leles) is about twice as frequent as HY (13 alleles).  In 
contrast, in African American donors from New York, 
HY (173 alleles) is more than five times as common 
as JO (33 alleles).  It is likely these findings reflect 
that Africans brought to South America were from a 
different region of Africa than those brought to the 
East Coast of North America.
Antibodies to antigens in the Dombrock blood 
group system are difficult to identify, and the paucity 
of reliable monospecific antisera hampers studies 
involving the Dombrock blood group system.  At 
least one anti-Hy has caused biphasic destruction of 
Hy+ RBCs.9  Other examples of anti-Hy as well as 
anti-Gya and anti-Joa have caused moderate transfu-
sion reactions (reviewed in Reid1).  PCR-based testing 
for DOA, DOB, HY, and JO alleles provides a tool 
to predict the probable phenotype of patients and 
blood donors.  This is an advantage for screening a 
large number of donors to find those who are Do(a–), 
Do(b–), Hy–, or Jo(a–), a feat not possible by hemag-
glutination.  Thus, for Dombrock typing, DNA-based 
assays are not only feasible, they are more reliable 
Table 1. Primers used for PCR-RFLP analyses
   Uncut Restriction 
 Primer  Size Enzyme Restriction Fragment Size 
 Name Primer Sequence (5´ to 3´) (bp)  (nt) (allele)
 DoF TACCTCACCTCAGCAATCCAGCTGCTGAGGAGAGAC 368 BseRI 326, 42 268, 58, 42
 DoR TTTAGCAGCTGACAGTTATATGTGCTCAGGTTCC  (nt 793) (DOA) (DOB)
DoX2F TCAGTACCAAGGCTGTAGCA 220 BsaJI (nt 323) 120, 92, 8 (DO) 212, 8 (HY)
Do378R AGTAAAGTCAGAATGAACATTGCTGCACAAT  XcmI (nt 350) 167, 53 (DO) 220 (JO)
nt = nucleotide; bp = base pairs; DO = DOA or DOB.
Table 2. Distribution of HY and JO alleles in donors of African 
descent in Brazil and New York
 Allele Brazilian Donors New York Donors 
 Combinations (n = 43) (n = 176)
 HY/DO 13 (30%) 132 (75%)
 HY/HY 0 14 (8%)
 HY/JO 0 13 (7%)
 JO/DO 30 (70%) 14 (8%)
 JO/JO 0 3 (2%)
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than hemagglutination. Our findings emphasize the 
importance of testing populations with different eth-
nic backgrounds to define their DO, and other blood 
group, alleles.
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